Brief: Initiator Pharma Q2 EBIT Loss Narrows To DKK 3.8 Mln
Aug 22 (Reuters) - Initiator Pharma A/S INIT.ST: Q2 OPERATING LOSS, EBIT WAS KDKK -3,844 (-4,491) Source text: ID:nMFN928X1g Further company coverage: INIT.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD